Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr845 Inhibitors

Olfr845, also known as OrX, represents a member of the olfactory receptor family, particularly in Mus musculus (house mouse). In the intricate realm of the olfactory system, Olfr845 plays a pivotal role as a sensory gatekeeper, allowing mice to perceive and interact with their environment through scent recognition. This member of the olfactory receptor family is akin to a molecular sentinel, stationed in the nasal epithelium, awaiting its crucial duty: the recognition of odorant molecules. As with other olfactory receptors, Olfr845 follows the common structural blueprint of G-protein-coupled receptors (GPCRs), boasting a seven-transmembrane domain structure that is fundamental for its functional prowess. The primary function of Olfr845 revolves around its extraordinary ability to interact with odorant molecules present in the environment. When an odorant molecule finds its way to Olfr845's binding site, a complex cascade of intracellular events is set into motion. This initiation leads to the activation of downstream signaling pathways, facilitating the transmission of signals that culminate in the perception of specific odors. The olfactory receptor gene family in mice, to which Olfr845 belongs, constitutes one of the most extensive gene families within the genome. It's noteworthy that the nomenclature assigned to olfactory receptor genes and proteins in mice is independent of their counterparts in other organisms.

Inhibition of Olfr845's function represents a multifaceted challenge, primarily because specific direct inhibitors for this receptor are not readily available. Therefore, indirect inhibition strategies emerge as potential avenues for altering Olfr845 activity. These indirect approaches often involve the modulation of cellular pathways and processes that are intertwined with Olfr845's function. For instance, targeting the PI3K/AKT pathway with inhibitors can lead to indirect Olfr845 inhibition by disrupting AKT phosphorylation, which plays a role in olfactory signal transduction. Similarly, compounds that impact the p38 MAPK pathway can indirectly influence Olfr845 by altering downstream signaling events related to olfaction. Additionally, the inhibition of the ERK/MAPK pathway can potentially suppress Olfr845 expression by blocking ERK phosphorylation, affecting its role in signal transduction. In conclusion, Olfr845 represents a critical player in the olfactory system of Mus musculus, functioning as a molecular sentinel that enables the perception of diverse odors. Its structural and functional characteristics align with those of other olfactory receptors, allowing it to fulfill its sensory role effectively.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol influences the SIRT1 pathway, potentially indirectly affecting Olfr845. It activates SIRT1, which may modulate downstream signaling cascades related to olfaction.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 targets the PI3K/AKT pathway, which could indirectly impact Olfr845 expression by inhibiting AKT phosphorylation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 affects the p38 MAPK pathway, potentially influencing Olfr845 through downstream signaling alterations.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits the ERK/MAPK pathway, which may indirectly suppress Olfr845 expression by blocking ERK phosphorylation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin targets PI3K, potentially affecting Olfr845 by modulating the PI3K/AKT pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which could indirectly lead to reduced Olfr845 expression through the mTOR signaling pathway.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin influences the NF-κB pathway, potentially affecting Olfr845 by reducing NF-κB activity and its downstream effects.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$38.00
$79.00
$188.00
$520.00
$1248.00
$5930.00
8
(1)

Niclosamide targets Wnt/β-catenin signaling, which may indirectly impact Olfr845 by modulating the Wnt pathway.

NFκB Activation Inhibitor II, JSH-23

749886-87-1sc-222061
sc-222061C
sc-222061A
sc-222061B
5 mg
10 mg
50 mg
100 mg
$214.00
$257.00
$1775.00
$2003.00
34
(1)

JSH-23 targets the NF-κB pathway, which could indirectly affect Olfr845 by reducing NF-κB activity and its downstream effects.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 modulates the TGF-β pathway, potentially impacting Olfr845 expression through downstream signaling alterations.